Is the Evaluation of Quality of Life in NSCLC Trials Important? Are the Results to be Trusted?

Overview of attention for article published in Frontiers in oncology, July 2014

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 15 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 10 publications that cite this research output.

10

The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.

Fluoxetine as a Potential Therapeutic Agent for Inhibiting Melanoma Brain and Lung Metastasis: Induction of Apoptosis, G0/G1 Cell Cycle Arrest, and Disruption of Autophagy Flux

Article in Journal of Cancer (May 2024)

Optimal sequencing strategies in the treatment of EGFR mutation–positive non–small cell lung cancer: Clinical benefits and cost-effectiveness

Article in American Journal of Health-System Pharmacy (September 2020)

Optimizing outcomes and treatment sequences in EGFR mutation-positive non-small-cell lung cancer: recent updates

Article in Future Oncology (August 2019)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.